Butterfly-shaped pigment dystrophy (MIM 608970) belongs to a group of autosomal dominant pattern dystrophies of the RPE, first described in a large Dutch family (family A; Fig. 1a ) [1] [2] [3] . The disease is characterized by accumulation of pigmented material in the macula that can resemble the wings of a butterfly 3 . From middle age, affected individuals present with either normal or slightly diminished best corrected visual acuity (BCVA) and color vision; the activity of the RPE as measured by electro-oculogram (EOG) recordings may be abnormal 4-6 . Responses of the retina, as recorded by full-field electroretinography (ERG), and dark adaptation are generally normal 4,7,8 . The disease is relatively benign but can progress to atrophy of the retina and underlying choroid in the macula 4,6,8 and to subretinal neovascularization 9 , both resulting in severe vision loss.
in the CTNNA1 gene (NM_001903: c.953T>C; p.Leu318Ser; phyloP score = 5.1). All affected relatives carried the variant in a heterozygous state, whereas the variant was absent from all unaffected family members. The variant, which was predicted to be disease causing by SIFT, affects a residue that is completely conserved among vertebrates (Supplementary Fig. 1 ) and was not found in 162 ancestry-matched controls or in the EVS database.
Sequencing of all 17 coding exons of the CTNNA1 gene in 93 unrelated probands with butterfly-shaped pigment dystrophy and other pattern dystrophies identified three additional rare missense variants in this gene ( Supplementary Table 1 ). Heterozygous variants c.1293T>G; p.Ile431Met and c.919G>A; p.Glu307Lys were identified in two probands of Dutch and Belgian ancestry, respectively (Fig. 1b) , and segregate with the disease in families B and C (Fig. 1a) . Both variants were predicted to be disease causing by PolyPhen and SIFT, affect residues that are conserved among vertebrates ( Supplementary  Fig. 1) , and were not identified in 162 ancestry-matched controls or in the EVS database. A third missense variant, c.160C>T; p.Arg54Cys, was identified in an Italian proband who presented with a small area of RPE atrophy superior to the fovea in the right eye, without classical phenotypical features seen in pattern dystrophies. The variant was predicted to be disease causing by PolyPhen and SIFT, affects a residue that is conserved among vertebrates ( Supplementary Fig. 1) , and was not identified in 200 ancestry-matched unrelated control individuals or in the EVS database but was present in the unaffected 64-year-old father of this individual. Therefore, the pathogenic nature of this variant remains unclear.
The clinical features of the affected individuals from the three families with butterfly-shaped pigment dystrophy are described in Supplementary Table 2 , and the results of retinal fundus photography, fluorescence angiography, near-infrared reflectance (NIR) imaging and ocular coherence tomography (OCT) are provided in Figure 2 .
Identification of a Ctnna1-mutant mouse model
An indirect ophthalmoscopy screen of mice from a B6J mutagenesis program identified a mutant, tvrm5, that showed widespread fundus mottling and occasional bright spots, often with dark centers (ring spots). Linkage analysis of a tvrm5 × DBA/2J intercross based on the ring spot phenotype identified a recessive disease-associated locus on chromosome 18 that was narrowed to a ~14.5-Mb interval by fine-mapping (distal to D18Mit22 and proximal to D18Mit236). Whole-exome sequencing identified coding variants in Ctnna1 (NM_009818: c.1307T>C; p.Leu436Pro; phyloP score = 2.6) and Pcdhb14 (c.1259C>T; p.Thr420Ile; phyloP score = 0.3). The higher phyloP score and predicted pathogenicity by SIFT of the Ctnna1 variant together with the much higher expression of Ctnna1 in the retina and RPE in comparison to Pcdhb14 (BioGPS; see URLs) implicated the Ctnna1 mutation as the causative allele. Through Sanger sequencing, this allele was confirmed to be homozygous in 17 affected progeny, heterozygous in two unaffected progeny and absent from eight unaffected progeny as well as B6J and DBA/2J mice, indicating cosegregation of the mutant allele with the ring spot phenotype. On the basis of the similarity of human CTNNA1-associated disease to that of tvrm5 mice, the mutant allele was denoted Ctnna1 tvrm5 . The distribution and expression of CTNNA1 protein and the expression of Ctnna1 mRNA in the posterior eye of B6J and heterozygous or homozygous mutant mice were similar ( Supplementary Figs. 2  and 3) , indicating that the missense mutation does not affect protein stability or expression.
RPE lesions and photoreceptor loss in Ctnna1 tvrm5 mice
Clinical disease assessment by bright-field fundus imaging of mice homozygous for Ctnna1 tvrm5 (Fig. 3a) demonstrated lesions in the central fundus biased toward the posterior pole that were correlated with the spot (Fig. 3c ) and ring spot ( Fig. 3d,e ) phenotypes. Fine pigment mottling was also detected throughout the fundus (Fig. 3a) . En face OCT images ( Fig. 3b) showed hyper-reflective objects at the same locations as observed by bright-field fundus imaging (Fig. 3b) . OCT B-scans of spots ( Fig. 3f ) showed localized thickening of hyper-reflectivity corresponding to the RPE and distortion of the photoreceptor inner-outer segment junction and external limiting membrane toward the vitreous. B-scans of ring spots showed localized thickening surrounding an elevated, hyporeflective core ( Fig. 3g,h) . Notably, the B-scan profiles of lesions in mice homozygous for Ctnna1 tvrm5 and human individuals with butterfly-shaped pigment dystrophy were similar, both for small and large lesions (compare Figs. 2e and 3f with Figs. 2i and 3h, respectively). OCT analysis also demonstrated a significant decrease in outer nuclear layer (ONL) thickness of ~9% at 1 and 3 months of age and ~15% at 12-14 months of age in mice homozygous for Ctnna1 tvrm5 as compared to wild-type B6J mice (Supplementary Fig. 4a ). In heterozygotes, mottling was more apparent with increasing age (Supplementary Fig. 4b ), but spots A r t i c l e s and ring spots were not evident by either fundus imaging or OCT, and ONL thickness was not significantly affected ( Supplementary  Fig. 4a ). Taken together, these findings indicate that pathological changes occur at the apical surface of the RPE or within the RPE itself and include the outer retina, where progressive photoreceptor loss is observed in mice homozygous for Ctnna1 tvrm5 (Fig. 3 and Supplementary Fig. 4a ).
Decreased light-activated RPE response in Ctnna1 tvrm5 mice
To test whether the morphological RPE defects were accompanied by a decrease in RPE function, we examined Ctnna1-mutant mice by direct current electroretinography (DC-ERG). In comparison to wild-type B6J mice, mice both heterozygous and homozygous for Ctnna1 tvrm5 at 1 year of age showed DC-ERG responses that were reduced in amplitude ( Fig. 4a) . When we quantified the main components of the response, significant differences from B6J mice were noted for the c-wave, fast oscillation and off-response in mice both heterozygous and homozygous for Ctnna1 tvrm5 (Fig. 4b) ; the reduction in amplitude for the light peak component, which tends to be variable in amplitude in mice, was not interpretable. Differences were not noted in the responses of heterozygous and homozygous Ctnna1-mutant mice. As DC-ERG signal is generated in response to rod photoreceptor activity 17 , it was essential to determine whether the reduced DC-ERG signals of Ctnna1-mutant mice resulted from a decrease in RPE function alone or the decrease in RPE function was accompanied by a decline in rod photoreceptor function. Therefore, we also recorded strobe flash ERGs for B6J and Ctnna1-mutant mice. Although the overall waveform did not differ across genotypes, the dark-adapted a-wave and b-wave amplitudes were both significantly reduced in mice homozygous for Ctnna1 tvrm5 as compared to B6J mice or mice heterozygous for Ctnna1 tvrm5 (Fig. 4c) . Thus, the reduction in DC-ERG responses in mice homozygous for Ctnna1 tvrm5 may reflect dysfunction of photoreceptors, RPE cells or both. By contrast, dark-adapted responses did not differ between heterozygous and B6J mice ( Fig. 4c) , indicating that the reduced DC-ERG response in heterozygous mice occurs without a loss of photoreceptor function. The cone ERG response was significantly reduced in mice homozygous for Ctnna1 tvrm5 in comparison to B6J or heterozygous mice ( Fig. 4d) .
Together with the live imaging results, the ERG observations support a pathogenic mechanism whereby mice heterozygous for Ctnna1 tvrm5 develop RPE dysfunction without substantial photoreceptor damage, whereas homozygous mice develop a more severe RPE functional deficit causing rod and cone photoreceptor cell loss.
Ectopic cells and inclusions in RPE of Ctnna1 tvrm5 mice
To assess cellular changes that might provide clues to the underlying cause of the RPE lesions and functional defects in Ctnna1 tvrm5 mice, we examined fixed retinal tissues by histology. In comparison to retina in B6J mice at 1 month of age ( Fig. 5a) , the retina in mice homozygous for Ctnna1 tvrm5 (Fig. 5b) was grossly normal apart from slight ONL thinning. However, in the homozygous mutants, outer retinal distortion was occasionally noted in areas where unusual features were found in the underlying RPE. First, ectopic pigmented cells were present on the RPE apical surface in focal lesions, appearing as a slightly thickened RPE layer contiguous with the epithelium (Fig. 5c ) or as a double layer ( Fig. 5d ). Single pigmented cells were also observed ( Fig. 5e ), which may be shed RPE cells. The observation of nuclei with no evidence of surrounding pigment ( Fig. 5f) suggested the presence of additional cell types in the subretinal space. Second, eosinophilic inclusions were found frequently within the RPE cell layer ( Fig. 5g) , often with an internal laminar appearance. npg Serial sections showed nuclei on the edges of these inclusions and sparse melanin pigment enclosed within a well-defined boundary, compatible with an intracellular location. Finally, pigmented cells on the RPE apical surface and eosinophilic inclusions were both present in larger lesions ( Fig. 5h-k) , suggesting a common pathogenic basis of these features. In agreement with live imaging results, these unusual features were observed at 1 month and at 12-14 months of age in homozygous mutant mice but were not detected in heterozygous or B6J mice. These findings provide a histological correlate of the live imaging results. The pigmented cells accumulating on the apical surface of the RPE (Fig. 5c,d ) corresponded to the bright spots observed by fundus imaging and en face OCT ( Fig. 3a,b ) and to the localized thickening of the hyper-reflective RPE layer in OCT B-scans ( Fig. 3f-h) . Accumulation of eosinophilic material in the epithelial layer ( Fig. 5g ) may also contribute to the localized thickening observed by OCT. Lesions containing large eosinophilic inclusions flanked by double layers of pigmented cells corresponded to the ring spots observed by live imaging (Fig. 5h-k) .
RPE dysmorphology and multinucleate cells
As an additional test for RPE structural defects, we stained RPEchoroid-sclera flatmounts from mice at 1 month of age to detect nuclei and the F-actin cytoskeleton at RPE cell boundaries. Flatmounts from B6J mice showed mono-and binucleate polygonal RPE cells with vertices shared by three cells (Fig. 6a) . In contrast, mice homozygous for Ctnna1 tvrm5 exhibited unusual RPE morphology comprising four or more cells surrounding an F-actin circle of variable size ( Fig. 6b-d ) or a shared vertex ( Fig. 6e) . Orthogonal views of B6J image stacks indicated that RPE nuclei are normally located below F-actin structures at the RPE apical surface ( Fig. 6f, left) , presumably microvilli 18 , and below the circumferential F-actin band that defines the polygonal cell boundary ( Fig. 6f, right) . In homozygous mutant mice, nuclei Post-hoc analysis (Tukey) indicated significantly reduced responses in Ctnna1 tvrm5 mice in comparison to B6J mice (*P < 0.003, **P < 0.0001), without significant differences between heterozygous and homozygous mutants (P > 0.05 npg A r t i c l e s were occasionally observed directly above the circular F-actin motif ( Fig. 6g) , consistent with apical shedding of an RPE cell. However, in most of these structures, nuclei were not apparent or were positioned basally to the circular F-actin motif, possibly indicating that basal shedding also occurs. RPE dysmorphology was also evident at 12-14 months of age. In comparison to the normal polygonal cells in B6J mice (Fig. 6h) , the RPE cells in mice heterozygous ( Fig. 6i) and homozygous ( Fig. 6j) for Ctnna1 tvrm5 were highly variable in size and included extremely large, irregularly shaped multinucleate cells. In addition to the absence of apical F-actin boundaries in the interior of these abnormal RPE cells, the disordered clustering of nuclei suggested a lack of intercellular barriers. Bright F-actin structures, including tangles and intense staining at the boundaries of rounded cells, were more pronounced in homozygous mutant than in heterozygous mice. In summary, a primary consequence of the Ctnna1 tvrm5 mutation appears to be considerable dysmorphology in the form of RPE cell shedding and the accumulation of large multinucleate RPE cells.
Structural and functional implications of CTNNA1 variants
CTNNA1 encodes α-catenin 1 (also known as αE-catenin or CTNNA1), which stabilizes intercellular adherens junctions as a force-sensing adaptor between cell surface cadherins and the actin cytoskeleton 19, 20 . CTNNA1 responds to increased intercellular npg tension by unfurling binding sites for actin-associated proteins such as VCL (vinculin), afadin, α-actinin and formin 19, 20 . Given the importance of adherens junctions for RPE integrity 21 , we explored possible structural and functional consequences of the CTNNA1 variants. The CTNNA1 variants detected in the three families with butterfly-shaped pigment dystrophy (p.Glu307Lys, p.Leu318Ser and p.Ile431Met) and the mouse Ctnna1 tvrm5 variant (p.Leu436Pro) are predicted to alter residues in CTNNA1 that are conserved among vertebrates (Supplementary Fig. 1 ). As shown on an X-ray crystallographic structural model of the human protein 22 (Fig. 7) , four of the five variants affect residues (Glu307, Leu318, Ile431 and Leu436) clustered in the middle of the protein. The variants map to the proposed force-sensing module (domains D3 and D4, residues 260-630) and to protein-binding domains within this module that may be sensitive to tension (D3a, residues 260-400; D3b, residues 400-507) (ref. 20) . The four variants map in or near the region reported to bind VCL 20,23-25 . The fifth variant, which is of uncertain pathogenic effect, alters Arg54 within the N-terminal domain that binds β-catenin, a direct binding partner of cadherin. To test for an effect of the variants on VCL binding, we coexpressed the wild-type and mutant CTNNA1 proteins heterologously with VCL. Although coimmunoprecipitations confirmed interaction of CTNNA1 with VCL, the mutations did not affect the interaction of these proteins (Supplementary Fig. 5 ).
DISCUSSION
This work implicates mutations in the CTNNA1 gene as a cause of butterfly-shaped pigment dystrophy. Previously, this condition has been associated with alterations in peripherin 2, a protein involved in outer-segment disc biogenesis of retinal photoreceptor cells 1 .
The finding that the disease is also caused by variants in CTNNA1, a central component of adherens junctions, broadens the perspective on its cellular and molecular basis. Intriguingly, a juvenile form of macular dystrophy (MIM 601553) that results in RPE atrophy and pigmentary changes has been linked to variants in CDH3, which encodes P-cadherin 26, 27 . Together, these findings support the idea that other components of the cadherin-based intercellular adhesion machinery may be implicated in macular degenerative disease. The parallel ocular phenotypes in affected human individuals carrying a CTNNA1 variant allele and in mice homozygous for the Ctnna1 tvrm5 allele suggest that there are similar mechanisms underlying pathogenesis in both species and that Ctnna1 tvrm5 mice accurately model the human disease. Notably, the dysmorphology of RPE cells in Ctnna1 tvrm5 mice raises the possibility that RPE defects are a precipitating event in the disease. Although disease phenotypes were stronger in mice homozygous for Ctnna1 trmv5 , RPE defects were also observed in heterozygous mice, implying a gene dosage effect. This effect likely arises from an altered function of the variant protein, as we found similar Ctnna1 mRNA and CTNNA1 protein expression levels in the posterior eye of wild-type mice and those heterozygous or homozygous for Ctnna1 tvrm5 . Although our work and previous studies [28] [29] [30] [31] (BioGPS) indicate that the mRNA and protein are expressed in both the RPE and retina, the disease phenotypes may be due to perturbation of CTNNA1 function specifically in the RPE. The human disease mainly affects the RPE 1-8 , whereas the mouse Ctnna1 tvrm5 mutation has only slight effects on retinal integrity and is less disruptive than an embryonic lethal gene-trap allele 32 or conditional knockout of Ctnna1 in retinal progenitor cells, which causes retinal developmental defects 29 . Thus, our results support a causative role of RPE defects in butterfly-shaped pigment dystrophy due to CTNNA1 variants.
The eosinophilic inclusions observed in RPE from mice homozygous for Ctnna1 tvrm5 appear similar to hard drusen, small dome-shaped eosinophilic masses between the RPE and Bruch's membrane that are associated with macular degeneration when abundant [33] [34] [35] [36] . The laminar substructure of the inclusions is sometimes evident in hard drusen 37 and resembles the 'onion skin' characteristic of drusen associated with Doyne honeycomb retinal dystrophy/Malattia leventinese 38 . As these inclusions correspond to elevated lesions in OCT B-scans, we surmise that similar lesions detected by OCT in patients with butterfly-shaped pigment dystrophy derive from eosinophilic inclusions in the RPE.
Pigmented cells on the RPE apical surface and aberrant F-actin structures in Ctnna1 tvrm5 mice were similar to shedding structures in chick embryonic RPE 39 and in mouse models of RPE injury 40, 41 . Shed RPE cells may survive to accumulate and/or proliferate locally at lesions, creating a double layer of pigmented cells, as observed in our study, in mouse models that target damage to the RPE 40, 42 and in geographic atrophy 43 . Alternatively, shed RPE cells may die and be phagocytosed by intact RPE or immune cells, yielding subretinal macrophages containing melanin pigment granules, as found in mouse models of retinal degeneration 44, 45 . We propose that RPE shedding is an initial event leading to focal RPE thickening and changes in melanin pigment distribution in CTNNA1-associated butterfly-shaped pigment dystrophy. RPE shedding may prove to be a common attribute of macular dystrophic disease, as subretinal pigmented cells and RPE cytoskeletal derangements similar to those observed in Ctnna1 tvrm5 mice have also been associated with human age-related macular degeneration 46, 47 .
Abnormally large multinucleate RPE cells in Ctnna1 tvrm5 mice may arise from RPE hyperproliferation and a cytokinesis defect due to the mutation, through repeated nuclear divisions without cell division. npg A r t i c l e s Alternatively, altered RPE cell adhesion due to the Ctnna1 tvrm5 mutation may lead to cell fusion and syncytia formation. For example, large multinucleate cells observed upon conditional deletion of Ranbp2 in mouse RPE were interpreted previously as syncytia 48 .
The positional clustering of pathogenic human and mouse variants within CTNNA1 suggests a shared effect on the activity of the protein. The variants may disrupt adherens junctions, which are critical for maintaining RPE integrity 21 . As the affinity of CTNNA1 variants for VCL was normal, the mutations may disrupt binding to other actin-associated proteins or alter the conformational response to mechanical stress. Recent studies demonstrated that CTNNA1 participates in molecular networks independent of cell adhesion, such as the NF-κB, Ras-MAPK, Hedgehog and Hippo signaling pathways. Consequently, the variants may perturb CTNNA1 function in cellular processes regulated by these pathways, including cytokinesis, cell differentiation or growth [49] [50] [51] .
Future studies may focus on other RPE cell adhesion components that contribute to macular disease and may uncover the mechanisms by which CTNNA1 dysfunction affects RPE turnover and proliferation and contributes to the pathogenesis of pattern dystrophy.
ONLINE METHODS
Clinical evaluations of human subjects. Fourteen affected and 12 unaffected individuals from three families with butterfly-shaped pigment dystrophy were included in this study. Participants received the diagnosis of butterfly-shaped pigment dystrophy on the basis of the aspect of the lesions on ophthalmoscopy sometimes in combination with fluorescein angiography. The medical histories, age at onset, BCVA and fundus appearance, including slit-lamp examination, fundus examination by indirect ophthalmoscopy and fundus photography, were retrieved from the medical records of all subjects included. Additionally, fluorescein angiography was available in 11 affected subjects, fundus autofluorescence and NIR images were obtained in six subjects and spectral-domain OCT data were obtained in four affected participants. Eleven affected subjects underwent EOG and ERG, and color vision testing results were available in six and seven affected subjects, respectively. ERG and EOG results were recorded and interpreted as previously described 52 . In six patients, EOG was performed according to the International Society for Clinical Electrophysiology of Vision (ISCEV) protocol. The study was approved by the local medical ethics committees (Commissie Mensgebonden Onderzoek regio Arnhem-Nijmegen, Ethics Committee of Ghent University Hospital and Ethical Committee of the Second University of Naples) and adhered to the tenets of the Declaration of Helsinki. All participants provided written informed consent before participation in the study.
Whole-exome sequencing and mutation analysis in human subjects.
To identify the genetic defect in a large Dutch family with nine individuals affected by butterfly-shaped pigment dystrophy (family A; Fig. 1a ), the DNA of two affected individuals (A-III:7 and A-III:11) was analyzed using wholeexome sequencing. The exomes were enriched using the SureSelect Human All Exon v.2 kit (50 Mb), which targets the exonic sequences of approximately 21,000 genes, according to the manufacturer's protocol (Agilent Technologies). Sequencing was performed on a 5500xl SOLiD sequencing platform (Life Technologies). BioScope software v.1.3 (Life Technologies) was used to map color space reads along the hg19 reference genome assembly. The highstringency calling DiBayes algorithm was used for single-nucleotide variant calling, and small insertions and deletions were detected using the small Indel Tool.
All coding exons and intron-exon boundaries of the CTNNA1 gene were screened for mutations in 93 unrelated probands with butterfly-shaped pigment dystrophy (n = 19) or other pattern dystrophies (n = 74) by Sanger sequencing. Primers for PCR amplification and sequencing were designed with Primer3 software ( Supplementary Table 3 The tvrm5 mutant (Jackson Laboratory, 021610) was identified among G 3 mice from an ethylnitrosourea mutagenesis screen of C57BL/6J mice (B6J mice; Jackson Laboratory, 000664) generated by the Center for New Mouse Models of Heart, Lung, Blood and Sleep Disorders at The Jackson Laboratory 53 . Phenotypic screening by indirect ophthalmoscopy at ~21 weeks of age was performed by the Translational Vision Research Models (TVRM) program 54 . Once heritability was established, tvrm5 mice were backcrossed to B6J mice for seven generations and maintained in a homozygous state by intercrossing. B6J mice were used as wild-type controls and in segregating crosses to generate heterozygous mice from the inbred mutant stock. tvrm5 mapping and sequence analysis. To identify the causative locus, a mutant tvrm5 male was outcrossed with a DBA/2J (+/+) female, the resulting F 1 progeny were intercrossed and 31 F 2 mice were analyzed for linkage using a pool scan with genome-wide SSLP markers. Map location was confirmed in individual F 2 mice from the pool, and additional SSLP markers were used to refine the map position. For whole-exome sequencing, genomic DNA (1 µg) was fragmented to a peak size of 300 bp by sonicating on low power (30-s power on/off cycle) for 10 min using Diagenode Bioruptor UCD-200TM-EX. The precapture pairedend library was constructed using the TruSeq DNA Sample Preparation kit (FC-121-100, Illumina) without a size selection step and 18 cycles of PCR. The precapture library was hybridized to the NimbleGen Mouse Exome capture probe set (9999042611, Roche NimbleGen) according to the manufacturer's instructions. The sequencing library was quantified by quantitative PCR, pooled with two similar libraries and sequenced on a single lane of a HiSeq 2000 instrument (Illumina) using a 2 × 100 bases (paired-end) sequencing protocol. Genotypes were confirmed by sequencing the PCR product amplified with primers Ctnna1F and Ctnna1R (Supplementary Table 3 ) at 97 °C for 3 min; 45 cycles of 95 °C for 10 s, 50 °C for 30 s and 72 °C for 30 s; and 72 °C for 3 min.
Quantitative RT-PCR and immunoblot analysis. For molecular analysis, the eyes of mice asphyxiated with carbon dioxide were removed and dissected immediately in ice-cold PBS to yield an RPE-choroid-sclera complex or placed in RNAlater (Thermo Scientific) at room temperature and punctured at the limbus with a needle. To recover RNA, the RPE-choroid-sclera complex was treated with RNAprotect (Qiagen) immediately following dissection and processed to yield a pigmented pellet enriched for RPE RNA 55 . Alternatively, enucleated eyes in RNAlater were dissected to recover the combined retina and RPE, which adhered tightly as evidenced by RPE nuclei and a polygonal melanin pattern on the retinal surface. Excess RNAlater was removed by micropipetting. The RPE-enriched pellet (two eyes per mouse) or the combined retina and RPE (one eye per mouse) was processed with the RNeasy Micro kit (Qiagen) as recommended by the manufacturer, including on-column DNase I treatment. Purified RNA was quantified using a NanoDrop 1000 spectrophotometer (Thermo Scientific). RNA was reverse transcribed with the RETROscript Reverse Transcription kit (Thermo Scientific) according to the manufacturer's instructions using random priming. Quantitative RT-PCR (qRT-PCR) was performed with iTaq Universal SYBR Green Supermix (Bio-Rad) and the Ctnna1rtF2 and Ctnna1rtR2 primers ( Supplementary  Table 3 ), using the CFX96 Real-Time PCR Detection System (Bio-Rad). The comparative C t method (∆∆C t ) was applied with Actb as an internal calibrator, and the relative fold change in Ctnna1 transcript levels was calculated as 2 −∆∆Ct . Melting curve analyses were performed to validate target gene amplification. Error bars represent the additive propagation of error calculated as described previously 56 .
For protein analysis, combined retina and RPE samples were resuspended and sonicated for 10 s in Laemmli sample buffer (Bio-Rad) containing Protease Inhibitor Cocktail Set III, EDTA-free (EMD Millipore) and 50 mM d,l-dithiothreitol. An equal volume of each lysate and a volume of a BJ6 lysate greater than and less than this volume were heated at 95 °C for 5 min and electrophoresed on Any kD Mini-PROTEAN TGX gels (Bio-Rad). Precision Plus Dual-Color Proteins were included to estimate protein molecular weights. Electrophoresed proteins were transferred to nitrocellulose with a Trans-Blot Turbo system (Bio-Rad) using the high-molecular-weight standard protocol. Blots were stained with Ponceau S for 1 h, washed twice with distilled water and imaged with visible light on a G:Box Chemi XRQ gel imaging system (Syngene). After blocking for 2-12 h at 4 °C in 5% nonfat dry milk in Trisbuffered saline containing 0.05% Tween-20 (TBST), blots were incubated overnight with a 1:1,000 dilution of rabbit monoclonal antibody to CTNNA1 (EP1793Y, Abcam) in blocking buffer. Following three 15-min washes with TBST, blots were incubated for 1.5 h at room temperature with a 1:1,000 dilution of goat anti-rabbit IgG conjugated with horseradish peroxidase (7074, Cell Signaling Technology), washed three times for 15 min each with TBST, developed with ECL Prime Western Blotting reagent (GE Healthcare Bio-Sciences) and imaged for chemiluminescence with the G:Box Chemi XRQ system.
To determine relative expression levels, TIF format images were quantified in Fiji 57 . Total protein was determined from Ponceau S images by first adjusting background intensity, subtracting a constant value over the entire image. The line tool was then adjusted to the width and full length of each lane, and the integrated density of the selected region was measured. A linear fit of total integrated density to load volume was determined in Excel (Microsoft) from the integrated intensities of B6J samples loaded at varying volumes and used to calculate the volume equivalent of each sample. A similar approach yielded volume equivalents for CTNNA1 staining from chemiluminescence images without background subtraction. The volume equivalent of CTNNA1 was divided by that of total protein, and the resulting values were tested statistically. Values from heterozygous and homozygous samples were averaged and divided by the corresponding B6J value to yield the relative expression level, which was graphed with the relative propagating error calculated from the square root of the sum of the squares of the relative error for each group.
Live imaging. Live fundus images were obtained with a Micron III Retinal Imaging System (Phoenix Research Laboratories) and an R2200 ultra-highresolution spectral domain OCT system (Bioptigen). Image acquisition and processing were performed as described previously 58 . ONL thickness in one eye of each mouse was determined from OCT volume data sets imported into Fiji at four positions, each ~250 µm from the optic nerve head in the superior, nasal, temporal and temporal fundus. Thickness was determined from 50pixel-wide lines drawn vertically across the ONL at each position. To identify the ONL boundaries reproducibly, the Plot Profile tool was used to plot image intensity by distance, and the length (in pixels) of a horizontal line between the midpoints of the intensity peaks on either side of the ONL was determined. Values from each eye were averaged and converted to ONL thickness by an axial factor of 1.53 µm/pixel determined from the OCT acquisition program.
Histology of mouse eyes. For conventional histology, the eyes of mice asphyxiated with carbon dioxide were removed and treated with a 3:1:4 mixture of methanol:acetic acid:PBS, with subsequent paraffin embedding and staining with hematoxylin and eosin as described 59 . Bright-field images were acquired using a Leica DMLB light microscope with 5× (HC PL FLUOTAR), 40× (HCX PL APO) and 100× (N PLAN) objectives. Images were collected using a QImaging Retiga 2000R camera and RGB Slider in color mode with QCapture software. Processing of exported image files in Fiji included gamma adjustment for color balance, brightness and contrast adjustment and unsharp mask. For immunohistochemistry, enucleated eyes were placed in Tissue-Tek optimal cutting temperature compound (Sakura Finetek) and snap frozen in 2-methylbutane chilled in liquid nitrogen. Cryosections (10 µm) were airdried on ColorFrost Plus glass microscope slides (Thermo Scientific), fixed for 10 min on ice with 4% paraformaldehyde in PBS and rinsed in PBS. Sections were blocked in PBS containing 0.3% Triton X-100 and 2% normal horse serum for 30 min at room temperature, followed by overnight incubation at 4 °C with rabbit monoclonal antibody to CTNNA1 (EP1793Y, Abcam) diluted 1:200 in blocking solution. Following three washes in PBS, sections were incubated for 1 h at room temperature in Cy3-conjugated F(ab′) donkey anti-rabbit IgG secondary antibody (711-166-152, Jackson ImmunoResearch) diluted 1:200 in blocking solution. Samples were washed three times in PBS and mounted on slides with VectaShield Mounting Medium with DAPI (Vector Laboratories). Stained slides were imaged with an LD Plan-Neofluar 20×/0.4 Korr Ph2 M27 or a Plan-Apochromat 100×/1.40 Oil M27 objective on a Zeiss Axio Observer Z.1 microscope with filter sets 43 or 49 using Zen 2012 software and a Hamamatsu ORCA-ER-1394 camera. Illumination intensity and exposure times were constant for all samples, and control sections that were treated identically except for the omission of primary antibody showed little to no fluorescence under the imaging conditions selected. At both magnifications, image brightness and contrast adjustments were applied uniformly across all samples in Fiji.
For flatmounts, enucleated eyes were fixed, dissected and stained with DAPI and rhodamine phalloidin as described for retina 58 , except that the RPEchoroid-sclera complex was retained and examined. Confocal image stacks were obtained using a Leica SP5 confocal microscope, HCX PL APO CS 63.0× /1.30 GLYC objective and Leica Acquisition Suite software. Conventional fluorescence images were obtained at 10× magnification (Plan-Apochromat 10×/0.45 M27) using the Zeiss filter sets and microscope system described above. Confocal images were processed in Fiji by dividing the blue by the green channel after denoising to reduce the contribution of autofluorescence to the DAPI signal, and images were oriented with the Interactive Stack Rotation plugin. An image stack subset was maximally projected to visualize the F-actin circumferential boundary with minimal overlap from apical F-actin. Conventional fluorescence image stacks were oriented with the Interactive Stack Rotation plugin to optimize the display of F-actin at RPE cell boundaries, and brightness and contrast were adjusted in Fiji.
Mouse electroretinography. Mice were studied using ERG stimulation and recording protocols to evaluate outer retinal and RPE function. Mice were adapted to the dark overnight, anesthetized with ketamine (80 mg/kg) and xylazine (16 mg/kg), and placed on a temperature-regulated heating pad throughout the testing sessions. Pupils were dilated with eye drops (2.5% phenylephrine HCl, 1% cyclopentolate, 1% tropicamide). The corneal surface was anesthetized with 1% proparacaine HCl.
Outer retina function was examined using a conventional strobe flash ERG protocol 60 . ERGs were recorded using a stainless-steel wire active electrode referenced to a needle electrode placed in the cheek. A second needle electrode placed in the tail served as ground lead. Responses were differentially amplified (0.3-1,500 Hz), averaged and stored using a UTAS E-3000 signal averaging system (LKC Technologies). White-light strobe flashes were initially presented in darkness within a Ganzfeld bowl with increasing luminance, from −3.6 to 2.1 log cd s/m 2 . Cone ERGs were isolated by superimposing stimuli (−0.8 to 1.9 log cd s/m 2 ) upon a steady adapting field (20 cd/m 2 ). The a-wave amplitude was measured 8 ms after flash onset from the prestimulus baseline. The b-wave amplitude was measured from the a-wave trough to the peak of the b-wave or, if no a-wave was present, from the prestimulus baseline.
RPE ERG components were examined using a DC-ERG protocol 60 . Responses were obtained from the corneal surface of the left eye using a capillary tube with filament (BF100-50-10, Sutter Instrument) filled with Hank's buffered salt solution to contact an Ag/AgCl wire electrode. A similar electrode contacting the right eye served as the reference. Responses were differentially amplified (dc-100 Hz), digitized at 20 Hz and stored using LabScribe Data Recording Software (iWorx). White-light stimuli were derived from an optical channel using a Leica microscope illuminator as the light source and delivered to the test eye with a fiberoptic bundle 1 cm in diameter. Stimulus luminance was 2.4 log cd/m 2 . Stimulus timing and duration were controlled at 7 min by a shutter system (Uniblitz). The c-wave amplitude was measured from the prestimulus baseline to the c-wave peak. The fast oscillation amplitude was measured from the c-wave peak to the trough of the fast oscillation. The light peak amplitude was measured from the fast oscillation trough to the asymptotic value. The off-response amplitude was measured from the light peak value just before stimulus light offset to the peak of the initial component.
Statistical analysis.
In mouse studies, which were exploratory, n ≥ 3 agematched animals were analyzed. The number of female and male mice used in each experiment is given in Supplementary Table 4 . Sample size pre-estimation, blinding and randomization were not implemented. All mice selected for quantitative studies were included in the statistical analysis. ONL thickness data at each age, DC-ERG component amplitudes for each stimulus condition, replicate ∆C t (Ctnna1 −Actb) values from qRT-PCR analysis and the ratios of CTNNA1 to total protein volume equivalents from immunoblotting were analyzed by one-way ANOVA. Statistically significant comparisons (P < 0.05) were further characterized by Tukey HSD post-hoc analysis. Response functions obtained for ERG a-wave and b-wave amplitudes were compared across genotypes using two-way repeated-measures ANOVA, with multiple comparisons by Tukey post-hoc analysis at each flash intensity. Assumptions for ANOVA modeling were met, as a quantile-quantile plot of ANOVA residuals against a normal distribution approximated the diagonal, and variances in each analysis except for the DC-ERG light peak response were found to be equal (Levene test). Statistical tests were performed with JMP (SAS) and Prism (GraphPad).
Coimmunoprecipitations.
Coimmunoprecipitation analyses were performed to test the interaction of wild-type and mutant CTNNA1 with VCL (vinculin; MIM 193065). Expression constructs to produce 3×HA-CTNNA1 (wild type
